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ABSTRACT 
All individuals are exposed to a large number of chemicals from multiple sources, and 
concern is growing that many everyday chemicals, alone or in combination, contribute 
significantly to observed increases in public health diseases. Bone tissue has been 
identified as a target for effects of environmental chemicals, however, possible 
consequences for human and wildlife health as well as the underlying mechanisms 
behind these effects are not yet well known. 
In the present thesis, bone tissue modulations following exposure to dioxins were 
characterized in experimental models, and the role of a functional aryl hydrocarbon 
receptor (AhR) for the observed effects, as well as for a normal bone phenotype, was 
investigated. The results show that exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin 
(TCDD) affects bone tissue in terms of altered geometrical, micro-structural, material 
and macro-mechanical properties. Osteoblast differentiation processes are affected by 
TCDD-exposure in vitro, which probably reflects one important cause for the 
disturbances of bone mineralization observed following in vivo exposure. Altered 
geometrical as well as densitometrical and micro-structural bone properties were 
associated with changes in circulating retinoid levels, which may reflect part of the 
observed bone modulations. Furthermore, altered expression of retinoid-related genes, 
as seen in osteoblastic cells following TCDD-exposure in vitro, might be a contributing 
mode-of-action underlying the disturbed osteogenesis process following dioxin 
exposure. A functional AhR is crucial for the manifestation of the observed dioxin-
induced effects, and also impacts the normal bone phenotype as lack of AhR resulted in 
slightly modified bone tissue properties, both similar and opposite to effects of TCDD-
exposure. Further, the outcome is clearly influenced by the timing of TCDD-exposure, 
as prenatal exposure resulted in delayed matrix maturation, while adult exposure caused 
a harder and stiffer bone matrix.  
Based on the observations in the experimental models in this study, the overall results 
show that environmental contaminants, to which humans are continuously exposed, 
have the ability to modulate the osteogenesis process. The functional consequences of 
such modulations should be further elucidated in order to establish any causal links 
between exposure to everyday chemicals and effects on the bone tissue properties, and 
possible contribution to bone disorders.  
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1 INTRODUCTION 
 
The industrialized society produces and handles numerous industrial chemicals, which 
are released into the natural environment. Many of these chemicals are so called 
persistent organic pollutants, which are long-lived compounds that can induce a broad 
range of pathological changes, affecting different organs and tissues. A variety of such 
compounds disrupts endocrine systems, and are usually referred to as endocrine 
disrupting compounds (EDCs). Originally EDCs were recognized to primarily cause 
reproductive effects. However, the group of compounds identified as EDCs has been 
found to be heterogeneous and to interact with various regulatory systems, affecting 
numerous signaling pathways, and new endpoints have been revealed as targets for 
EDCs. Bone, whose process for turnover and homeostasis is dependent on complex 
interactions of various cell types as well as of both local and systemic factors, such as 
hormones, growth factors and cytokines, is a potential target for the insult by chemicals 
with EDC properties. Emerging evidence has shown that exposure to compounds that 
bind to the aryl hydrocarbon receptor (AhR) can interfere with bone tissue. In the 
present thesis, bone tissue modulations following exposure to dioxin and dioxin-like 
compounds have been characterized, and the role of AhR for the observed effects was 
investigated. Quantitative approaches were used to evaluate both in vivo and in vitro 
endpoints, and possible associations with retinoid system disturbances in the 
manifestation of bone modulations were assessed.  
 
 
1.1 DIOXINS AND DIOXIN-LIKE COMPOUNDS  
Dioxins and related compounds are persistent organic pollutants that are ubiquitously 
present in the environment, resulting in continuous exposure of both humans and 
animals. These chemicals elicit a similar spectrum of toxicological responses through a 
common mechanism of action, but with variable potency. Reported health effects 
include reproductive impairment, developmental toxicity, immunotoxicity, 
neurotoxicity, hepatotoxicity, carcinogenesis, cardiovascular toxicity, skin toxicity, 
bone and tooth toxicity, and disruption of endocrine signaling systems, as well as a 
number of biochemical changes (White and Birnbaum 2009). 
 
The most potent and toxic congener in the group of dioxins is 2,3,7,8-
tetrachlorodibenzo-p-dioxin (TCDD), which is often used as a model substance for 
these types of compounds. In the ambient environment, dioxins and dioxin-like 
compounds are always present as mixtures, also containing non-dioxin-like 
compounds. The contribution of the non-dioxin-like congeners to the toxicity of such 
mixtures is largely unclear, as are their mechanisms of action. However, pattern of 
effects showing both differences and similarities with dioxin-like congeners have been 
demonstrated (Elabbas et al. 2013). As experimental studies have mostly focused on 
exposure to single compounds, not much is known about the possible implication on 
the effect pattern and adversity by the exposure to a combination of multiple 
environmental chemicals. For dioxin-like compounds, however, the system of so called 
toxic equivalency factors (TEFs) has been established in order to compare the potency 
of a compound, or a mixture of compounds, to produce toxic effects relative to that of 
TCDD (Table 1). For inclusion in the TEF concept, a compound must show a structural 
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relationship to the dioxins, be persistent and accumulate in the food chain, bind to the 
AhR and elicit AhR-mediated biochemical and toxic responses (Van den Berg et al. 
2006). The group of dioxins and dioxin-like compounds includes polychlorinated 
dibenzo-p-dioxins (PCDDs) and polychlorinated dibenzofurans (PCDFs), which are 
by-products of certain industrial processes and combustion. Also some of the 
polychlorinated biphenyl (PCB) congeners, which constitute a group of industrial 
chemicals used in transformers and capacitors, are classified as dioxin-like due to their 
biological activity. 
 
Table 1. Toxic equivalency factors for polychlorinated dibenzo-p-dioxins, polychlorinated dibenzofurans 
and dioxin-like polychlorinated biphenyls. 
Compound  TEF Compound TEF 
Polychlorinated dibenzo-p-dioxins   Dioxin-like polychlorinated biphenyls  
2,3,7,8-TCDD  1 3,3´4,4´-tetraCB  (PCB 77) 0.0001 
1,2,3,7,8-PeCDD  1 3,4,4´,5-tetraCB (PCB 81) 0.0003 
1,2,3,4,7,8-HxCDD  0.1 3,3´4,4´5-pentaCB (PCB 126) 0.1 
1,2,3,6,7,8-HxCDD  0.1  3,3´4,4´,5,5´-hexaCB (PCB 169) 0.03 
1,2,3,7,8,9-HxCDD  0.1 2,3,3´4,4´-pentaCB (PCB 105) 0.00003 
1,2,3,4,6,7,8-HpCDD 0.01  2,3,4,4´,5-pentaCB (PCB 114) 0.00003 
OCDD 
Polychlorinated dibenzofurans 
2,3,7,8-TCDF 
1,2,3,7,8-PeCDF 
2,3,4,7,8-PeCDF 
1,2,3,4,7,8-HxCDF 
1,2,3,6,7,8-HxCDF 
1,2,3,7,8,9-HxCDF 
2,3,4,6,7,8-HxCDF 
1,2,3,4,6,7,8-HpCDF 
1,2,3,4,7,8,9-HpCDF 
OCDF 
0.0003 
 
0.1 
0.03 
0.3 
0.1 
0.1 
0.1 
0.1 
0.01 
0.01 
0.0003 
2,3´4,4´,5-pentaCB (PCB 118) 
2´,3,4,4´,5-pentaCB (PCB 123) 
2,3,3´,4,4´5-hexaCB (PCB 156) 
2,3,3´,4,4´,5´-hexaCB (PCB 157) 
2,3´,4,4´,5,5´-hexaCB (PCB 167) 
2,3,3´,4,4´,5,5´-heptaCB (PCB 189) 
0.00003 
0.00003 
0.00003 
0.00003 
0.00003 
0.00003 
 
 
1.1.1 The aryl hydrocarbon receptor  
Most of the toxic effects of dioxins and dioxin-like compounds are mediated via 
activation of the AhR, a ligand-activated transcription factor belonging to the Per-
ARNT-Sim (PAS) family of proteins (Hankinson 1995). The AhR is ubiquitously 
expressed in most organs and cells in the body, and besides its role in responses to toxic 
xenobiotic chemicals, it is also thought to play important roles in normal cell 
physiology. Mice lacking a functional AhR are largely resistant to the toxicity of 
TCDD, but also have a number of phenotypical abnormalities such as immune system 
impairment, liver fibrosis, heart hypertrophy and dermal fibrosis (Fernandez-Salguero 
et al. 1995; Gonzalez and Fernandez-Salguero 1998), providing strong evidence for a 
physiological role of the AhR. No definitive endogenous AhR-ligand has been 
identified, however, a number of candidates have been suggested, including 
arachidonic acid metabolites, heme metabolites, tryptophan metabolites and UV 
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photoproducts of tryptophan, as well as natural flavonoids and indole-3-carbinol 
derivatives (Denison and Nagy 2003; Nguyen and Bradfield 2008). 
 
The AhR interacts with numerous other signaling pathways (reviewed in Puga et al. 
2009), and it has been demonstrated that the presence or absence of AhR affects the 
expression of almost as many genes as TCDD-induced activation of the AhR, but with 
partly different expression pattern (Tijet et al. 2006). It is therefore likely that the toxic 
effects of exposure to potent and persistent AhR-ligands such as dioxins, are results of 
dysregulation of normal AhR activation, leading to inappropriate gene regulation and 
signaling in target cells (Bock and Kohle 2006). As illustrated in Figure 1, unliganded 
AhR resides in the cytosol, bound to a chaperon complex (rewieved in Petrulis and 
Perdew 2002). Ligand binding to the AhR induces translocation into the nucleus (Ikuta 
et al. 2000; Pollenz 1996) and release of the chaperons and heterodimerization of AhR 
with its partner protein aryl hydrocarbon receptor nuclear translocator (ARNT) (Heid et 
al. 2000; Reyes et al. 1992). In the nucleus, the AhR-ARNT heterodimer can bind to 
xenobiotic response elements (XREs) in the promoter region of target genes (reviewed 
in Swanson 2002) and regulate gene transcription. After transcription, AhR dissociates 
from ARNT and translocates in to the cytosol, where it is degraded (Davarinos and 
Pollenz 1999). The AhR activity can be regulated by various mechanisms. One such 
mechanism is negative feedback regulation by the AhR repressor (AhRR), whose 
expression is induced upon activation of the AhR (reviewed in Hahn et al. 2009). The 
exact mechanism by which the AhRR inhibits the AhR is not clear, but it has been 
hypothesized that it competes with AhR for heterodimerization with ARNT and 
binding to the XRE (Mimura et al. 1999). 
 
 
 
Figure 1. Illustration of the mechanisms behind ligand-activation of AhR-induced transcriptional 
regulation.  
 
 
1.1.2 Interactions between the AhR and the retinoid system 
The retinoid system is known to be a target in dioxin toxicity, and the disturbances of 
retinoid signaling is proposed to be involved in the effects of dioxins (Murphy et al. 
2007; Nilsson and Hakansson 2002; Novak et al. 2008; Zile 1992). Alterations of the 
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retinoid system have therefore been suggested as an endpoint in the evaluation of 
chemicals with endocrine disrupting properties (OECD 2011). Retinoids play an 
essential role in the development and homeostasis of tissues, and both deficiency and 
excess have been associated with malformations (Zile 2001). Retinoids are non-steroid 
hormones that are obtained from the diet, and are present as several different forms, 
including retinyl esters, retinol, retinal and retinoic acids. In addition, a number of 
enzymes and binding proteins are associated with the retinoid metabolism and transport 
(Blomhoff and Blomhoff 2006). An overview of the retinoid metabolism and signaling 
in the cell is shown in Figure 2. Retinoids are mainly stored in the liver in the form of 
esters, and transported as retinol to provide tissues with optimal retinoid amounts 
(Blomhoff and Blomhoff 2006). In the cell, retinol is converted via retinal to all-trans 
retinoic acid, which is the signaling retinoid form. All-trans retinoic acid binds to 
retinoic acid receptors (RARs), thereby regulating the expression of retinoid target 
genes. All-trans retinoic acid can be further metabolized to generate retinoic acid 
isomers, of which some binds to RARs and/or retinoid X receptors (RXRs), while other 
are excreted.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2. Retinoid metabolism and signaling in target cells. Reprinted from (Novak et al. 2008) with 
permission from Elsevier.  
atRA: all-trans retinoic acid; CRBP: cellular retinol binding protein; CRABP: cellular retinoic acid binding 
protein; CYP: cytrochrome P450; R: retinol; RA: retinoic acid; RAL: retinal; RALDH: retinaldehyde 
dehydrogenase; RAR: retinoic acid receptor; RARE: retinoic acid response element; RBP: retinol-binding protein; 
RXR: retinoid X receptor; RXRE: retinoid X response element;TTR: transthyretin. 
 
  
Exposure to dioxins and dioxin-like compounds induces tissue- and cell-specific 
changes in retinoid levels (reviewed in Nilsson and Hakansson 2002), and various 
interactions between the AhR- and retinoic acid-signaling pathways have been 
demonstrated (reviewed in Murphy et al. 2007). The mechanisms behind these 
observations are not well known, but it is likely that interactions between the AhR and 
retinoic acid pathways have the ability to modulate the synthesis, metabolism, storage 
and transport of retinoids, as well as transcriptional regulations (Murphy et al. 2007). 
AhR-knockout mice are shown to have reduced retinoic acid metabolism and elevated 
hepatic levels of retinoic acid, retinol and retinyl palmitate (Andreola et al. 1997), as 
well as altered retinoid and thyroxin metabolic response following TCDD-exposure 
(Nishimura et al. 2005). Modulations of the levels of signaling retinoids, which are 
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ligands to RARs and RXRs, are likely to alter the expression of retinoid-responsive 
genes, thereby having potential consequences for retinoid-regulated systems. Hundreds 
of genes have been suggested to be regulatory targets of retinoic acid (Balmer and 
Blomhoff 2002), indicating that a disturbed retinoid signaling could have the capacity 
to affect various systems, which is compatible with the profile of dioxin toxicity that 
includes a broad range of effects. 
 
 
1.2 BONE TISSUE 
Bone is a specialized form of connective tissue in which the extracellular matrix is 
mineralized. The bone tissue can be divided into cortical and trabecular (also called 
cancellous) bone. Cortical bone is compact and builds the outer shell of the bone, while 
trabecular bone is more sponge-like in structure, and is located inside of the cortical 
bone shell, in long bones mostly at the end sections. The micro-structure of cortical 
bone consists of cylindrical structures called osteons (Figure 3). The osteons are built of 
plate-like layers of bone matrix, the lamellae, which are wrapped around a central 
canal, the Haversian canal, containing nerves and blood supplies of the bone. The 
micro-structure of trabecular bone is also composed of lamellae, but which are arranged 
in an irregular network of rod- and plate-like elements, called trabeculae, instead of 
osteons. The lamellae of both osteons and trabeculae are built of mineralized collagen 
fibers, which consist of bone mineral crystals (hydroxyapatite, calcium carbonate, 
magnesium hydroxide, fluoride and sulfate), collagen molecules and other proteins (e.g. 
osteopontin, bone sialoprotein, osteocalcin and osteonectin) (Rho et al. 1998).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3. Hierarchical organization of bone. Reprinted from (Rho et al. 1998) with permission from 
Elsevier. 
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Bone strength is dependent on both geometrical, micro-structural and material 
properties of the bone. The bone tissue has to be stiff enough to resist deformation upon 
loading, but also flexible enough to be able to change in shape without breaking when 
load is applied. The collagen fibers in the matrix provide elasticity and flexibility, and 
the minerals that are crystallized onto the collagen fibers give the hardness of the bone 
(Burstein et al. 1975). If the degree of mineralization is too high, the stiffness increases 
but the flexibility decreases, making the bone more brittle. If the degree of 
mineralization is too low, the flexibility of the bone tissue increases while the stiffness 
decreases, resulting in the bone bending too much when load is applied.    
 
Bone tissue is formed by endochondral or intramembranous ossification.   
Endochondral bone formation, which takes place in long bones, develops via a 
cartilaginous template that is remodeled into mineralized bone, while intramembranous 
bone formation, which takes place in flat bones, is formed without a cartilaginous 
template (Marks and Odgren 2002). Bone is a dynamic tissue that is continuously 
remodeled in order to renew the bone and repair microfractures, and to meet the 
mechanical needs. The bone tissue can adapt in terms of changes in mineral density, in 
disposition of trabeculae and osteons, and in terms of shape and dimensions (Turner 
1998). A schematic overview of bone cell types involved in bone remodeling is shown 
in Figure 4. Osteoclasts are multinucleated cells, derived from hematopoietic stem 
cells, which resorb bone by acidification and proteolysis of the bone matrix. 
Osteoblasts are derived from mesenchymal stem cells, and work in clusters during the 
formation of new bone, which occurs by deposition of collagen followed by 
mineralization of the matrix. Osteocytes, which are the most abundant cell type in 
mammalian bone, are mature osteoblasts that at the end of the bone formation phase 
have become embedded in the matrix. Osteocytes form an interconnected network of 
cells that are thought to have the capacity to sense mechanical loads and detect 
microfractures in the bone, and respond by activating osteoclasts (Cullinane 2002; 
Heino et al. 2009; Xiong and O'Brien 2012). Also lining cells, which are covering the 
surface of mineralized bone matrix, originate from osteoblasts and are suggested to be 
involved in controlling the microenvironment and signals regulating bone remodeling 
(Miller et al. 1989).  
 
Figure 4. Illustration of cell types involved in the bone remodeling process. 
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Bone remodeling is regulated by both systemic and local factors, such as hormones and 
cytokines. One central regulatory system is the OPG/RANKL/RANK system that 
constitutes a direct interaction between the osteoblast-linage cells and osteoclasts 
(Hofbauer et al. 2000; Xiong and O'Brien 2012). The osteoblasts express the receptor 
activator of nuclear factor κB ligand (RANKL), which binds to the receptor activator of 
nuclear factor κB (RANK) on osteoclast precursors and stimulate differentiation of 
osteoclasts. Osteoblasts also produce osteoprotegerin (OPG) that blocks the effects of 
RANKL. This system thereby ensures that the processes of resorption and formation of 
bone are tightly coupled and thus in equilibrium.  
 
 
1.3 DIOXIN-RELATED BONE TISSUE ALTERATIONS  
An increasing number of studies suggest that bone tissue should be considered as a 
target in environmental toxicology. It has been observed that exposure to dioxins and 
dioxin-like compounds has the ability to modulate bone tissue in terms of altered bone 
geometry, bone mineral density and bone strength. Jämsä et al. (2001) studied bone 
effects in adult rats of two strains with different AhR-structures, following long-term 
exposure to TCDD, and demonstrated decreased cross-sectional and medullary areas, 
as well as reduced mechanical strength of tibial diaphysis (Jamsa et al. 2001). Further, 
the difference in sensitivity to dioxin-induced bone alterations between the two rat 
strains indicated that the observed effects on bone are AhR-dependent (Jamsa et al. 
2001). Miettinen et al. (2005) studied the effects of TCDD on developing rat bone 
following maternal exposure at different times of gestation and lactation, and showed 
decreased cross-sectional area and bone mineral density, as well as reduced 
mechanical strength of tibia, femur and femoral neck. The effects were found to be 
dependent on the timing of exposure, as earlier exposure caused more pronounced 
effects, while at the age of one year, along with discontinued exposure, most of the 
effects were reversed (Miettinen et al. 2005). Consistent with the findings by Jamsa et 
al. (2001), the TCDD-induced bone effects were observed mainly in offspring of the 
rat strain with a wild-type AhR, and less in rats with an altered receptor type 
(Miettinen et al. 2005). Decreased tibial trabecular area, increased bone mineral 
density and alteration of the chemical composition of bone were shown following 
short-term TCDD-exposure of adult rats (Lind et al. 2009b), and mice exposed to 
TCDD via lactation showed reduction in mineralized bone in the proximal end of tibia 
(Nishimura et al. 2009). Bone effects of TCDD-exposure have also been shown for 
other species. Hermsen et al. (2008) reported increased cross-sectional bone area and 
bone mineral content in female rhesus monkey, and altered macro-mechanical 
properties in the males, following in-utero and lactational TCDD-exposure (Hermsen et 
al. 2008). Studies in fish have shown malformations of craniofacial skeletal structures 
and underdeveloped ribs in rainbow trout sac-fry (Hornung et al. 1999), malformation 
of bone in medaka (Kawamura and Yamashita 2002), and disrupted bone growth in 
medaka embryos (Dong et al. 2012), following exposure to TCDD.   
 
In addition to TCDD, also other dioxin-like compounds have been demonstrated to 
affect bone. Exposure of rats to PCB126, the most dioxin-like PCB congener, has been 
shown to result in increased cortical thickness (Lind et al. 2004; Lind et al. 1999), 
higher organic bone content and larger osteoid surface (Lind et al. 1999), and decreased 
mechanical strength and changes in the composition of the organic matrix (Lind et al. 
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2000) of long bones. Further, decreased degree of mineralization, altered bone mineral 
composition and increased trabecular bone mineral density has been demonstrated in 
rat vertebrae following exposure to PCB126 (Alvarez-Lloret et al. 2009). Exposure of 
nestling american kestrels to PCB126 has been shown to result in decreased skeletal 
growth (Hoffman et al. 1996), and chicks from PCB-exposed hens showed deformities 
of legs, feet, and skulls (Summer et al. 1996). Fetuses of ewes exposed to PCB153 were 
shown to have decreased cross-sectional bone area, thicker cortical bone, decreased 
marrow cavity and increased bone mineral density of femurs (Gutleb et al. 2010). 
Further, sheep exposed to PCBs, among other contaminants, through contaminated 
pastures, showed alterations in femoral bone areas and mineral density (Lind et al. 
2009a; Lind et al. 2010). Both skull bone and long bone of terrapins were affected by 
exposure to PCB126, resulting in altered geometrical and densitometrical properties 
(Holliday and Holliday 2012), and frogs exposed to a metabolite of 1,1,1-trichloro-2,2-
bis (p-chlorophenyl)-ethane (DDE) showed decreased cortical bone mineral density 
(Lundberg et al. 2007). Exposure to Aroclor 1254, a PCB mixture containing both 
dioxin-like and non-dioxin-like congeners, was shown to result in decreased cross-
sectional and cortical bone areas, and proportionally smaller medullary area, as well as 
increased bone mineral density and reduced bone strength of long bone in rats 
(Andrews 1989). Also decreased collagen content in long bones (Ramajayam et al. 
2007) and alterations of cortical bone structure in vertebrae (Yilmaz et al. 2006) has 
been reported following exposure of rats to Aroclor 1254.  
 
Perinatal exposure to the AhR-ligand 3-metylcholatren (3MC) resulted in abnormalities 
and delayed ossification of metacarpals and metatarsals in mouse foetuses (Naruse et 
al. 2002). Further, the CA-AhR mouse, which has a constitutively active AhR and is 
used as a model for effects of continuous low-level activation of the AhR (Brunnberg et 
al. 2006), has been observed to have a bone phenotype differing from wild-type mice, 
such as higher cross-sectional and trabecular bone areas, higher trabecular bone mineral 
content, and macro-mechanical properties indicative of less brittle bone (Wejheden et 
al. 2010). 
 
A number of wild-life studies have found correlations between exposure to 
organochlorine mixtures, which usually contains dioxins and/or dioxin-like 
compounds, with alterations of bone tissue. Grey seals from the Baltic Sea sampled 
during the period of high organochlorine contamination showed bone loss in skulls 
(Bergman et al. 1992) and lower trabecular bone density of radius (Lind et al. 2003), 
compared to seals collected during periods with lower contamination. Reduced bone 
mineral density of skulls has been associated with high concentrations of 
organochorines, including PCBs, also in polar bears (Sonne et al. 2004). In otters, 
elevated muscle concentrations of PCBs have been related to increased cortical area, 
cortical thickness and cortical bone mineral content (Roos et al. 2010). Alligators from 
a pesticide contaminated lake showed increased bone mineral density (Lind et al. 
2004), and bank voles from a dioxin contaminated area were shown to have reduced 
strength of femural neck (Murtomaa et al. 2007). Clapper rail chicks from a site 
contaminated with PCBs, among other toxicants, showed altered chemical composition 
of the bone (Rodriguez-Navarro et al. 2006), and skeletal deformities in grey heron 
chicks have been linked to organochlorine contamination (Thompson et al. 2006). 
Herring gulls from organochlorine contaminated areas had shorter and thinner femoral 
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bone with lower mineral density (Fox et al. 2008). Fish exposed to pulp mill effluents, 
containing organochlorines, have shown vertebral deformities and altered mechanical 
properties of vertebrae (Bengtsson et al. 1988). 
 
Only a few epidemiological studies have assessed correlations between dioxin-related 
exposure and changes of bone tissue properties in humans. There are studies that give 
support for a high dietary intake of organochlorines as a risk factor for vertebral 
fractures (Alveblom et al. 2003), and indications that exposure to organochlorine 
affects bone mineral density (Hodgson et al. 2008). But there are also studies that 
provide minor or no support for an association between organochlorine exposure and 
effects on bone mineral density (Cote et al. 2006; Glynn et al. 2000) or risk of 
osteoporotic fractures (Wallin et al. 2004). Further, levels of DDE in serum has been 
suggested to correlate with reduced bone mineral density in women (Beard et al. 
2000), while another study showed no correlation between DDE-exposure and bone 
mineral density (Bohannon et al. 2000). 
 
In vitro studies have reported dioxin-induced effects on both osteoblasts and 
osteoclasts. Modulation of osteoblast differentiation was demonstrated following 
exposure to TCDD (Carpi et al. 2009; Gierthy et al. 1994; Korkalainen et al. 2009; 
Koskela et al. 2012; Ryan et al. 2007; Singh et al. 2000), Aroclor 1254 (An et al. 2012), 
as well as 3MC (Naruse et al. 2002). Exposure to 3MC was shown to also affect the 
differentiation and fusion, but not the resorption activity, of osteoclasts (Naruse et al. 
2004). Consistently, TCDD-exposure of osteoclasts had no effect on the number or 
activity of osteoclasts (Ilvesaro et al. 2005), but affected osteoclast differentiation 
(Korkalainen et al. 2009; Koskela et al. 2012). Also benzo[a]pyrene has been shown to 
affect osteoclastogenesis (Voronov et al. 2005; Voronov et al. 2008). Expression of 
the AhR has been demonstrated both in histological bone sections (Ilvesaro et al. 2005), 
and in osteoblasts and osteoclasts in vitro (Ilvesaro et al. 2005; Korkalainen et al. 2009; 
Naruse et al. 2002). Further, the AhR-antagonist resveratrol has been shown to inhibit 
TCDD-induced effects on osteoblasts (Singh et al. 2000), and consistently, osteoblastic 
cells from AhR-knockout mice were unaffected by TCDD (Korkalainen et al. 2009), 
suggesting the effects to be mediated through the AhR. Resveratrol also partially 
inhibited the effects of 3MC (Naruse et al. 2004) and benzo[a]pyrene (Voronov et al. 
2005) on osteoclastic cells.  
 
In spite of the associations between dioxin exposure and modulations of bone, both in 
vivo and in vitro, the mechanisms behind the observed effects are not well understood. 
As signaling systems are sensitive to chemical interference, the regulation of bone 
tissue homeostasis is a potential target for any disturbances that might cause imbalance 
in the regulation of bone modeling and remodeling. An adequate retinoid status is 
important for bone homeostasis, and effects on bone by retinoid excess have been 
demonstrated both experimentally in vivo and in vitro, and in humans (reviewed in 
Conaway and Lerner 2011). Both osteoblasts and osteoclasts express receptors for 
retinoic acid (Kindmark et al. 1993; Saneshige et al. 1995), and the significance of 
retinoid signaling in skeletogenesis is established (Weston et al. 2003). In humans, both 
too high (Feskanich et al. 2002; Melhus et al. 1998; Michaelsson et al. 2003; 
Opotowsky and Bilezikian 2004; Promislow et al. 2002) and too low (Opotowsky and 
Bilezikian 2004) retinoid intake has been associated with reduced bone strength. In 
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rodents, retinoid excess has been reported to result in altered bone properties, such as 
bone geometry and strength (Dhem and Goret-Nicaise 1984; Hough et al. 1988; 
Johansson et al. 2002; Kneissel et al. 2005; Lind et al. 2011). Moreover, it has been 
demonstrated that knock-out of the retinaldehyde dehydrogenase (RALDH3), which 
synthesize retinoic acid, blocks TCDD-induced cleft palate in mice, suggesting that 
retinoid signaling is necessary for TCDD to induce alteration of palate development  
(Jacobs et al. 2011). Further, in TCDD-exposed rats, serum levels of retinoids have 
been shown to be altered (Fletcher et al. 2005) at the same doses where effects on bone 
properties, especially altered bone geometry, have been observed (Jamsa et al. 2001). 
These findings suggest that the retinoid system may have a role in mediating bone 
toxicity by AhR-ligands.  
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2 AIMS OF THE PRESENT STUDY 
 
 
The general objective of this thesis was to in detail characterize the effects of dioxins 
on bone tissue, and to investigate the role of AhR and retinoid system disturbances for 
the observed effects.  
 
The specific aims were to: 
 
o Characterize the effects on bone geometry, mineral density, micro-structure 
and bone material and macro-mechanical properties following adult, as well as 
perinatal, exposure to TCDD (papers I, II, III). 
 
o Investigate the role of a functional AhR for TCDD-induced bone modulations 
(papers I, III), and for normal bone phenotype (paper III). 
 
o Study bone modulations following exposure to a mixture of dioxin-like and 
non-dioxin-like PCB-congeners, and elucidate qualitative and quantitative 
similarities to the effects of TCDD (papers IV, V). 
 
o Investigate the role of TCDD-induced retinoid system disturbances in relation 
to effects of bone tissue properties and osteoblast differentiation (paper VI). 
 
o Apply the benchmark dose methodology in the evaluation of bone parameters 
to derive effects doses and relative potency values (papers I, IV, V). 
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3 COMMENTS ON METHODOLOGY 
 
3.1 PERIPHERAL QUANTITATIVE COMPUTED TOMOGRAPHY  
Peripheral quantitative computed tomography (pQCT) is an X-ray based technique 
used for assessment of geometrical and densitometrical properties of bone. The method 
has the ability to differentiate between cortical and trabecular bone tissue, and generates 
volumetric information from cross-sections of the bone. Examples of images from 
pQCT analyses are shown in Figure 5.  
 
 
 
 
 
 
Figure 5. Examples of pQCT images at different sites of tibial bone. 
 
By pQCT, the geometry of different bone compartment, as well as the bone mineral 
content and mineral density, are calculated. Also approximations of the macro-
mechanical properties of the bone are provided by using the cross-sectional information 
about the bone sample (Gasser 1995). The pQCT scans generate a number of 
parameters, of which the most commonly used ones are listed in Table 2.  
 
Table 2. Parameters generated by pQCT analyses. 
Parameter  Description 
Total bone mineral content  The mineral content of the bone within a bone slice 
Cortical bone mineral content  The mineral content of cortical bone within a bone slice  
Trabecular bone mineral content  The mineral content of trabecular bone within a bone slice 
Total bone mineral density  The mean volumetric density of the bone 
Cortical bone mineral density  The mean volumetric density of the cortical bone  
Trabecular bone mineral density  The mean volumetric density of the trabecular bone  
Total bone area  The cross-sectional area of the bone  
Cortical bone mineral area  The area of the cortical bone  
Trabecular bone mineral area  The area of the trabecular bone  
Periosteal circumference The outer bone circumference 
Endosteal circumference The inner circumference of the cortical bone 
Cortical thickness The thickness of the cortical shell 
Polar moment of inertia Indication of the resistance to rotation of the bone 
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3.2 MICRO-COMPUTED TOMOGRAPHY 
Micro-computed tomography (µ-CT) is, similarly to pQCT, an X-ray based method for 
evaluation of bone properties. Compared to pQCT the µ-CT has a higher resolution, 
which gives more detailed information at the level of bone micro-structure. Examples 
of images from µ-CT analyses are shown in Figure 6. 
 
 
 
 
 
 
 
Figure 6. µCT images of tibial bone showing various numbers of trabeculae. 
 
The higher resolution also results in less so called partial volume effect, which in 
pQCT-analyzes might affect the estimations of densitometrical values (Feretti 1999). 
As with the pQCT, a number of parameters are generated by µ-CT analyses, of which 
the most commonly used ones are listed in Table 3. 
 
Table 3. Parameters generated by µ-CT analyses. 
Parameter  Description 
Bone volume fraction  The fraction of a given volume that is occupied by bone 
Trabecular thickness  Thickness of individual trabeculae 
Trabecular separation  Thickness of the spaces between trabeculae 
Trabecular number  Number of trabeculae in a bone region 
Trabecular bone pattern factor  Indication of connectivity of the trabeculae  
Structural model index  Indication of the relative prevalence of rod- and plate-like trabeculae 
Porosity The proportion of the cortical area that consist of enclosed spaces 
Polar moment of inertia Indication of the resistance to rotation of the bone 
  
 
 
3.3 THREE-POINT BENDING TEST 
In order to evaluate the mechanical strength of bone, beyond the estimations by pQCT 
and µ-CT, biomechanical analyses are used. Three-point bending test (Figure 7A) is a 
method to analyze the bending strength of long bones (Leppanen et al. 2006). When a 
force is applied, the bone will start to deform and an internal resistance to the applied 
force is generated. The change in dimension is plotted against the load in a stress-strain 
curve (Figure 7B), which gives information about the macro-mechanical properties of 
the bone.  
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Figure 7. A) Three-point bending test (sketch by N Stern). B) Strain-stress curve 
 
 
The linear part of the curve is the elastic region. During this stage of the bending, there 
are no permanent changes of the bone shape, and the bone is able to return to its 
original position if the loading is stopped. The slope of the elastic region gives the 
stiffness of the bone. If the load increases the curve will become non-linear, which is 
the plastic region. While in the plastic region, the bone is being permanently deformed 
by the load, and ultimately it will break. The main parameters received from the stress-
strain curve in three-point bending test are listed in Table 4. 
 
 
Table 4. Parameters generated by three-point bending test. 
Parameter  Description 
Maximum breaking force  The force at which the bone breaks 
Deformation  Deformation at the point of maximum breaking force 
Stiffness  Stiffness of the bone  
Energy absorption  The energy the bone is able to store until it brakes 
 
 
 
3.4 NANOINDENTATION 
Nanoindentation is a technique that can be used to evaluate mechanical properties of 
bone matrix. Such nano-mechanical bone parameters give information of the matrix 
material properties. In this approach the cortical and trabecular bone are evaluated 
separately. A very fine diamond tip is loaded to the surface of the bone sample, and the 
loading and unloading of the tip is recorded (Ozcivici et al. 2008). An image of 
indentation sites in cortical bone is shown in Figure 8A. A load-displacement curve is 
obtained (Figure 8B), and the parameters are derived from the response of the material.  
 
 
 
 
 
 
 
 
A B 
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Figure 8. A) Indents in cortical bone. Reprinted from (Finnila et al. 2010), with permission from 
Elsevier. B) Load-displacement curve. 
 
 
Both dynamic and quasistatic loading can be applied, allowing for different nano-
mechanical properties to be evaluated. Elastic modulus is calculated from the slope of 
the elastic region of the unloading curve, and the hardness is given by the displacement 
at the maximal load. When the load is increased, the material is undergoing both elastic 
and plastic deformation. If the load is held constant (hold period), a time-dependent 
deformation is seen, the so called creep behavior, which describes the structural 
damage to the material from loading. The main parameters received from the load-
displacement curve in nanoindentation tests are listed in Table 5. 
 
 
Table 5. Parameters generated by nanoindentation test. 
Parameter  Description 
Indentation hardness  Resistance to permanent deformation  due to a constant load 
Elastic modulus  Describes the elasticity on the material 
Storage modulus  Describes the elastic portion of viscoelastic materials 
Loss modulus  Describes the viscous portion of viscoelastic materials 
Plasticity index  The ability to permanently change in shape without breaking 
Creep amplitude  Describes the structural damage to the material from loading 
 
 
     
3.5 CELL LINE AND MARKERS OF OSTEOBLASTIC DIFFERENTIATION 
The murine calvarial osteoprogenitor cell line MC3T3-E1 was used to study effects on 
osteoblast differentiation. Osteoblasts differentiate from progenitor cells into 
proliferating pre-osteoblasts, and further into bone matrix-producing osteoblasts. The 
differentiation of osteoblasts occurs in three principal phases, which are proliferation, 
extracellular matrix maturation and mineralization (Lian and Stein 1995). During these 
phases there are temporal expressions of differentiation-related genes that can be used 
as markers for osteoblast differentiation. MC3T3-E1 cells are shown to display such 
sequential expression analogous to in vivo bone formation, therefore providing a useful 
model for studying osteoblast differentiation (Quarles et al. 1992). In the present study, 
the mRNA expression of runt-related transcription factor 2 (RUNX2), alkaline 
phosphatase (ALP) and osteocalcin (OCN) were used (Figure 9). RUNX2 is a 
B A 
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transcription factor that is expressed during proliferation, ALP is expressed prior to the 
initiation of mineralization, and OCN is expressed in differentiated osteoblasts (Ducy 
2000; Lian and Stein 1995). 
 
 
 
 
 
 
 
 
Figure 9. Principal phases of osteoblast differentiation and corresponding markers.  
RUNX2: runt-related transcription factor 2; ALP: alkaline phosphatase; OCN: osteocalcin. 
 
 
3.6 BENCHMARK DOSE MODELING 
The benchmark dose (BMD) approach has been suggested as an alternative to the 
derivation of the “No Observed Adverse Effect Level” (NOAEL) or “Lowest Observed 
Adverse Effect Level” (LOAEL) in health risk assessment of chemicals. NOAEL is 
defined as the highest dose which does not cause statistically significant effects, and the 
LOAEL as the lowest dose which cause effects. In comparison to the NOAEL/LOAEL 
approach, the BMD method makes more use of the dose-response data and the BMD is 
not limited to be one of the experimental doses, which makes the results less dependent 
on the study design in terms of experimental dose levels and dose spacing.  
 
To derive BMDs, a dose-response model is fitted to the experimental data, and the 
BMD corresponding to a certain level of response is estimated (Slob 2002) (Figure 10). 
This level of response, called critical effect size (CES), or benchmark dose response 
(BMR), is for continuous data typically a pre-defined percentage change relative to the 
background level of the particular endpoint (Sand et al. 2008; Slob 2002). 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 10. Schematic dose-response curve. A BMD is indicated in comparison to NOAEL and LOAEL.   
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The CES should represent a non-adverse but biologically relevant change in the 
response for a certain endpoint, and EFSA has recommended a CES of 5% as a default 
starting value (EFSA 2009). However, for some endpoints this effect level might not be 
relevant from a biological point of view, and especially for in vitro endpoints, such as 
effects on enzymes or gene expression, it is difficult to define a biologically appropriate 
CES. Also for endpoints not traditionally used in toxicological studies, where there is 
little knowledge about the consequences and adversity of the effect, a consensus 
regarding useful effect levels is lacking. 
 
 
 
3.7 PARTIAL LEAST SQUARE 
Partial least square (PLS) analysis is a multivariate regression method that is used to 
model the relationships between explanatory variables and response variables (Wold et 
al. 2001). PLS analyzes allows for geometrically visualization of the relations between 
the explanatory and response variables that are projected in two- (or more) dimensions, 
and thus associations between variables are ascertained.  
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4 RESULTS AND DISCUSSION 
 
4.1 EFFECTS OF DIOXIN ON BONE TISSUE 
 
Long bones are suitable for the evaluation of effects on geometry, mineral density 
and macro-mechanical properties in studies of dioxin-induced bone toxicity 
In paper I, the effects of exposure of adult rats to TCDD were analyzed at different 
bone sites; long bones (femur and tibia), femoral neck and lumbar vertebra. The results 
show that in particular the cross-sectional geometry of long bones was a sensitive and 
consistently affected endpoint of TCDD-exposure of adult rats. Both periosteal and 
endocortical circumferences of tibia and femur were decreased, resulting in reduced 
cross-sectional, cortical and trabecular areas. Further, exposure to TCDD decreased 
trabecular bone mineral density of femur, and the lower maximal breaking force, 
stiffness and energy absorption of long bones indicated less stiff bones with lower 
ability to absorb energy. Such weakness would result in an increased risk of fracture at 
lower load.  
 
The results from paper I suggest that analyses of long bones are more suitable for 
evaluation of effects on geometry, mineral density and macro-mechanical properties of 
bone in studies of dioxin-induced bone toxicity, than are femoral neck and lumbar 
vertebra. This finding does not necessarily reflect that long bones are more sensitive to 
TCDD-induced effects, but could be due to methodological reason, such as measuring 
reproducibility. However, it has been shown that the tibial and femural metaphysis 
reacts with the greatest magnitude of change to interventions such as ovariectomy 
(Gasser 1995), which may be true also for effects of dioxins.  
 
TCDD-exposure during development affects the bone matrix maturation process 
The exposure to environmental chemicals is of special concern for fetuses and infants 
as it occurs during the most vulnerable time-points of organ system development. In 
paper II, the effects of perinatal TCDD-exposure on bone tissue was evaluated for rat 
offspring at post-natal days (PND) 35 and 70. In particular, the material properties of 
cortical bone were studied using nanoindentation. The nano-mechanical parameter 
storage modulus describes the elasticity and stiffness of a material, hardness is a 
measure of the resistance to permanent deformation due to the load, and plasticity index 
reflects the ability to permanently change shape in response to the force without 
breaking. During normal bone matrix maturation, storage modulus and hardness is 
increased along with increase of the bone mineral content, while plasticity index 
decreases (Zioupos 2005; Zioupos and Currey 1998). When these parameters were 
compared between the offspring at PND 35 and PND 70 in paper II, the normal 
pattern was seen for the unexposed rats as the modulus and hardness was higher at 
PND 70 than at PND 35, and the plasticity index was lower. However, the TCDD-
exposed rats did not show significant changes in these parameters between PND 35 and 
PND 70 (Figure 11), indicating that exposure to TCDD during development delays the 
normal bone matrix maturation process.  
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Figure 11. Nano-mechanical bone parameters A) modulus, B) hardness, and C) plasticity index in control 
(full line) and TCDD-exposed (dashed line) rat offspring at PNDs 35 and 70. Reprinted from (Finnila et 
al. 2010), with permission from Elsevier. 
 
 
In addition to affecting bone material properties, TCDD-exposure also decreased the 
cross-sectional area and the cortical thickness, as well as reduced the cortical bone 
mineral density. The cross-sectional moment of inertia (reflecting the resistance to 
rotation) and moment of resistance (reflecting the resistance to bending) was decreased, 
as were also the bending force and stiffness of the bone. These results suggest that 
prenatal exposure to TCDD led to softer and more ductile bone, as indicated by less 
increase of the storage modulus and hardness, and less decrease of plasticity.  
 
The mineral content of the bone is contributing to the major part of the elastic stiffness 
of the bone, whereas the plastic properties depend on the collagen (Burstein et al. 
1975). The lower storage modulus, which is related to the mineral component of the 
bone, indicates a lower mineral-to-collagen ratio. Also the decreased bending force and 
stiffness is in agreement with lower mineralized bone in relation to the collagen 
content. When correlations between the affected parameters were analyzed, the bending 
force and stiffness showed stronger correlations with the mineralization and 
geometrical parameters, such as cortical bone mineral density and cortical area, than 
with the nano-mechanical parameters. The mechanical strength of whole bone depends 
on both geometry and bone material properties, and the results in this study indicate 
that the reduced bone strength observed in TCDD-exposed offspring was mainly a 
consequence of the altered bone geometry and mineralization level, rather than of 
changes in the bone material properties. 
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TCDD-exposure alters the micro-structure and material properties of bone  
Bone tissue can be considered at multiple hierarchical levels, as illustrated in Figure 3, 
and bone quality is determined by structural as well as material properties. However, 
not much is known about the effects of dioxin toxicity on bone tissue at the level of 
micro-structure. In paper III, the effects of exposure of adult mice to TCDD were 
analyzed by µ-CT and nanoindentation, in addition to pQCT and three-point bending 
test. TCDD-exposure decreased the endosteal circumference of metaphysis, while the 
periosteal circumference was unaffected, resulting in a smaller trabecular area but 
unaffected cross-sectional area. Normally, the bone grows through resorption at the 
endosteal surface and lying down of bone on the periosteal surface, resulting in the 
bone becoming larger with a larger medullary area (Jaworski 1981), however, a smaller 
medullary or trabecular area have been observed also in other studies following 
exposure to TCDD (Herlin et al. 2010; Jamsa et al. 2001; Lind et al. 2009b) or PCBs 
(Andrews 1989). In spite of the smaller trabecular area, the trabecular bone volume 
fraction was increased, due to an increased number of trabeculae (Figure 12). This was 
also reflected by increased trabecular bone mineral density, which most likely is due to 
the increased trabecular number and not to bone mineral density increase in individual 
trabeculae. The difficulties to distinguish between a “real” increase in mineral density 
and increased number of trabeculae, using pQCT, are due to the voxel size of the pQCT 
that is of the magnitude of the trabecular thickness. Consequently, the voxels consist 
only partially of the bone tissue while the rest is bone marrow, resulting in so called 
partial volume effect (Feretti 1999). When, as in this study, the trabecular bone volume 
fraction is increased, there is more bone tissue in a given volume, which increases the 
apparent bone mineral density.  
 
 
 
Figure 12. Bone tissue of unexposed (left) and TCDD-exposed (right) mice in paper III, illustrating the 
difference in trabecular bone volume fraction (image by M Finnilä). 
 
 
Although the mineral density of the trabeculae themselves did not seem to be altered, 
the hardness and elastic modulus were increased, which indicated that the trabecular 
bone matrix became harder and stiffer. Further, the structural model index of trabecular 
bone was decreased by TCDD-exposure, indicating a more plate-like shape of the 
trabeculae. The finding of the trabeculae being more plate-like in shape is unlike the 
osteoporotic bone phenotype, for which the trabeculae are characterized by a more rod-
like structure (Wehrli et al. 2001). The cortical bone was affected in terms of decreased 
thickness and increased porosity, and similarly to the trabecular bone matrix, the 
hardness and elastic modulus were increased by TCDD-exposure, indicating a harder 
cortical bone matrix.  
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As bone remodeling involves both removal of mineralized bone and formation of new 
bone matrix that becomes mineralized, imbalances in any of these processes affect the 
bone material properties. TCDD-exposure decreased the ratio of the bone formation 
marker procollagen I amino-terminal propeptide (PINP) and the bone resorption marker 
collagen I carboxy terminal telopeptide (CTX) in serum, indicating unbalanced bone 
remodeling. Consistent with these results, Lind et al. (2009) reported decreased PINP 
levels and increased CTX levels in combination with a decreased trabecular bone area 
and increased bone mineral density in tibial metaphysis, in rats following short-term 
TCDD-exposure (Lind et al. 2009b). Further, they showed that the chemical 
composition of bone was affected, resulting in bone minerals with characteristics of 
more mature bone, while the degree of mineralization was unaffected (Lind et al. 
2009b). The altered bone material and macro-mechanical properties in paper III, 
resulting in harder and stiffer bone matrix, also resemble characteristics of more mature 
bone. No effect was seen on plasticity index, indicating that the collagen properties, 
which are contributing the most to the plastic response of the bone (Burstein et al. 
1975), were not affected. The expression of genes related to osteogenesis was affected 
by TCDD-exposure, with mostly down-regulated genes, whereas a few genes were up-
regulated (paper III, Figure 3), further suggesting that the observed bone properties 
following TCDD-exposure might be a result of impaired remodeling.  
 
In comparison with the bone tissue effects following perinatal TCDD-exposure in 
paper II, which resulted in delayed matrix maturation and decreased stiffness, the 
results in paper III suggest that exposure to TCDD in adulthood causes a harder, stiffer 
and more brittle bone tissue. This is likely to reflect the differences between affected 
bone modeling and matrix maturation from start, versus impaired remodeling of 
existing mineralized bone matrix.  
 
TCDD inhibits late phases of osteoblast differentiation in vitro  
In paper V, TCDD was observed to affect the phases of matrix maturation and 
mineralization in osteoblastic cells (Figure 13), while no effects on proliferation were 
observed, which is consistent with previous findings (Korkalainen et al. 2009).  
 
 
Figure 13. Time-course effects of TCDD on the expression of ALP and OCN (paper V). 
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When comparing exposure only during the first part of differentiation (day 0-6) or only 
during the later part of differentiation (day 11-20), no differences in effects on the 
expression of differentiation markers were seen. This finding suggests that the timing 
of exposure during osteoblast differentiation is not important, although the long half-
life of dioxin might contribute to this finding.  
 
It has been suggested that TCDD affects osteoblast differentiation and function by 
altering the cell architecture, adhesive properties and calcium homeostasis (Carpi et al. 
2009). As osteocalcin is implicated in bone mineralization, the finding of decreased 
osteocalcin expression might suggest consequences for the mineralization process. This 
is in line with the findings in both paper II and paper III, which indicates that 
exposure to TCDD affects the mineralization of bone, although with different outcome 
depending of the timing of exposure. Perinatal exposure resulted in softer bone, while 
adult exposure caused harder and stiffer bone. Osteoblasts originate from the 
mesenchymal stem cells  that also give rise to adipocytes and chondrocytes, and it has 
been demonstrated that these cell lineages have the ability to transdifferentiate, even 
when already pre-commited, so that cells of the osteoblastic linage could switch to 
become adipocytes or chondrocytes, and vice versa (Song and Tuan 2004). An 
especially close inter-relationship has been shown between the osteoblastogenensis and 
adipogenesis pathways (Beresford et al. 1992; Nuttall and Gimble 2004; Park et al. 
1999; Schilling et al. 2007), and these interactions have gained interest in the 
pathogenesis of osteoporosis (Meunier et al. 1971; Nuttall and Gimble 2004). It could 
therefore be speculated that exposure to TCDD has the ability to drive the cells towards 
an adipocyte or chondrocyte lineage pathway in the expense of osteoblasts, thereby 
affecting mineralization. Another process that may potentially be affected is the 
transition of osteoblasts into osteocytes. A proportion of osteoblasts at the end of the 
bone formation phase transforms into osteocytes, which are thought to have important 
roles in bone remodeling. An inappropriate differentiation of osteocytes could be 
expected to impact the mineralization of bone, and it has been suggested that 
accelerated osteoblast-to-osteocyte transition leads to a bone matrix with reduced 
osteoid and increased mineralization (Laue et al. 2011). 
 
Aroclor 1254 exhibits dioxin-like bone effects in-vivo and in-vitro  
In the environment, dioxins and dioxin-like compounds are present as mixtures 
together also with non-dioxin like compounds, and in paper IV, bone effects of 
exposure to the PCB-mixture Arocor 1254, which contains both dioxin-like and non-
dioxin-like congeners, were studied. Perinatal exposure to Arocor 1254 affected bone 
geometry, mineral density and macro-mechanical properties of young rat offspring, 
while in older offspring, along with discontinued exposure of Aroclor 1254, these 
effects where no longer detectable. The bone effect pattern elicited by perinatal 
exposure to Aroclor 1254 was similar to the effects observed by perinatal TCDD-
exposure in paper II, including decreased cross-sectional area, cortical thickness and 
cortical bone mineral density, as well as bending force and stiffness. It has been shown 
that there is not always a sharp border between the effect patterns of dioxin-like and 
non-dioxin-like PCB-congeners (Elabbas et al. 2013). Based on estimated TCDD 
equvivalents for the bone effects by Aroclor 1254 compared with the toxic equivalent 
(TEQ) value calculated from the congener content in the mixture, the results indicate 
that the effects of Aroclor 1254 were mainly driven by the dioxin-like congeners.  
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In paper V, it was shown that Aroclor 1254 also affects osteoblast differentiation in 
vitro similar to TCDD, as evaluated by the expression of the marker genes RUNX2, 
ALP and OCN, although the maximal effects are lower and the doses required were 
higher compared to TCDD. In order to estimate whether only the dioxin-like 
congeners, or also non-dioxin-like congeners, are driving these effects, relative potency 
(REP) values calculated from EC50-values, were compared to REP-values based on the 
chemical composition of Aroclor 1254. The REP-values for the decreased expression 
of ALP and OCN were shown to be similar to, or slightly lower, than the REP-value 
based on the chemical composition, suggesting, consistent with the in vivo results in 
paper IV, that the observed effects are mainly driven by the dioxin-like congeners in 
Aroclor 1254. This is also illustrated by similarities of the dose-response curves when 
the doses of TCDD and Aroclor 1254 are expressed as TEQ, visualizing the impact of 
the dioxin-like components in Aroclor 1254 alone (Figure 14).  
 
 
 
Figure 14. Dose-response curves for the decreased expression of A) ALP and B) OCN following  
Aroclor 1254 (triangles) and TCDD (circles) exposure, with the doses expressed as TEQ (paper VI). 
 
 
It cannot, however, be excluded that also non-dioxin-like congeners, which act via non-
AhR-dependent modes-of-action and therefore are not taken into account in the TEF 
system, contribute to the exposure outcome. As the estimated potency of Aroclor 1254 
was lower than the REP-values based on the dioxin-like constituents in the mixture, 
such contribution seems to be inhibitory rather than additive or synergistic. In order to 
elucidate possible contribution of non-dioxin-like components in the mixture, these 
congeners should be tested also separately. The consistency of the quantitative 
estimations between the in vivo and in vitro findings in papers IV and V, suggests that 
ALP and OCN expression are useful as markers for dioxin-like effects on bone.  
 
Dioxin-induced effects on bone differ partly between the genders 
In paper III, the effects of TCDD on bone were shown to partly differ between the 
genders. Effects on the cortical bone structure, such as cortical porosity, as well as 
parameters describing the material properties, were more pronounced in females, and 
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also the macro-mechanical properties of the whole bone were mainly seen in females. 
The effects on trabecular bone micro-structure, and the decrease in trabecular bone 
area, were seen for both genders, while effects on trabecular bone material properties 
were more pronounced in males. Not many bone toxicity studies have included 
investigations of both males and females, and there is no study which did a detailed 
quantitative evaluation of the data to clarify any possible gender differences due to 
TCDD-induced bone toxicity. Semi-quantitative and qualitative data analyses resulted 
in reports on no differences between the genders for bone effects of TCDD following 
perinatal and lactational exposure (Miettinen et al. 2005), while perinatal and 
lactational TCDD-exposure of rhesus monkeys resulted in altered bone geometry and 
composition in females, but only a few macro-mechanical parameters affected in 
males (Hermsen et al. 2008). Female CA-AhR mice, which have a constitutively active 
AhR, were shown to differ considerably more in bone phenotype compared to wild-
type mice, than did the males (Wejheden et al. 2010). For the bone effects elicited by 
perinatal exposure to Aroclor 1254 in paper IV, there were no gender differences 
observed, while the dioxin-like PCB126 has been shown to cause somewhat different 
effects depending on estrogen status (Lind et al. 2004). It is likely that differences in 
effects of dioxin-like compounds between the genders are due both to hormonal status 
and to exposure regimens such as timing of exposure. Therefore more detailed 
evaluation of available data and/or systematic studies are needed to fully elucidate any 
gender differences in dioxin-induced bone toxicity. 
 
 
4.2 THE ROLE OF AHR  
Dioxin-induced modulations of bone are dependent on the AhR  
Previous studies have indicated that bone toxicity belong to the category of dioxin 
effects that are dependent on the AhR (Jamsa et al. 2001; Miettinen et al. 2005). The 
differences between the Long-Evans (L-E) and Han/Wistar (H/W) rat strains in 
sensitivity to a number of dioxin-induced toxic effects have been ascribed to the 
structurally aberrant AhR, with an insertion/deletion type of alteration at the 3’ end of 
the coding region of cDNA and a smaller receptor size (Pohjanvirta et al. 1998), 
exhibited by the more TCDD-resistant H/W strain (Tuomisto et al. 1999). In paper I, 
the sensitivity differences to insults of TCDD on adult bone between the L-E and H/W 
rat strains were investigated using the BMD methodology. Of the bone parameters 
where both strains showed effects, there was a 10-fold strain difference for decreased 
energy absorption of proximal tibia and tibial length, and a 50-fold strain difference for 
decreased cross-sectional area of proximal tibia, while for six parameters there was no 
difference between the strains. For many of the analyzed bone parameters, covering 
both geometry, mineral density and macro-mechanical properties, only the L-E rats 
showed significant dose-response relationships, while the H/W rats were largely 
unaffected. In paper III, where bone effects of TCDD-exposure were compared for 
AhR+/+ and AhR-/- mice, TCDD caused only a few alterations of the bones of AhR-/- 
mice. In male AhR-/- mice, the cortical porosity was decreased following TCDD-
exposure, which is opposite to the increased cortical porosity seen for TCDD-exposed 
AhR+/+ mice. Neither the material properties nor trabecular micro-structure were 
affected by TCDD in the AhR-/- mice, and consistently, TCDD did not affect the levels 
of the bone remodeling markers PINP or CTX. The expression of a few osteogenesis-
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related genes was altered by TCDD exposure in AhR-/- mice, but the pattern of affected 
genes was not the same as for AhR+/+ mice. In paper V, the marker genes for osteoblast 
differentiation in vitro were decreased at the same doses where the expression of AhR-
dependent genes was induced, indicating that these effects occur only when the AhR is 
activated (paper V, figures 3 and 5). Taken together, these findings strongly support 
that altered bone tissue properties following dioxin exposure are highly dependent on 
the AhR. 
 
Absence of a functional AhR modifies the bone phenotype  
In paper III, the impact of the AhR on normal bone phenotype was investigated, and it 
was found that lack of AhR resulted in slightly modified bone tissue properties, which 
also partly differed between the genders. Principally, the AhR-/- mice had higher 
trabecular bone volume fraction with lower trabecular separation and increased number 
of trabeculae, compared to AhR+/+ mice. These properties are similar to the alterations 
seen following TCDD-exposure of AhR+/+ mice, although less pronounced in the AhR-/- 
mice. For female AhR-/- mice the trabecular bone matrix tended to be softer and more 
elastic, which is opposite to the TCDD-exposure that caused harder and stiffer bone 
matrix. Together with the serum levels of bone resorption- and formation markers, 
these findings are indicative of a higher bone remodeling rate, resulting in 
undermineralization that makes the bone more elastic and less stiff (Seeman 2003).  
 
 
4.3 THE RETINOID SYSTEM IN DIOXIN-INDUCED BONE TISSUE 
MODULATIONS 
In paper VI, the effects on serum levels of retinoids were analysed in the same mice, 
which were characterized for bone tissue modulations in paper III. It was shown that 
exposure to TCDD increased the serum retinol levels. The TCDD-induced modulations 
of bone tissue in paper III showed several similarities with bone properties that have 
been reported following retinoid treatment, such as increased trabecular bone mineral 
density, decreased trabecular bone area, harder and stiffer trabecular bone matrix, as 
well as reduced cortical thickness and cortical bone mineral density (Hough et al. 1988; 
Johansson et al. 2002; Kneissel et al. 2005; Li et al. 1989; Lind et al. 2011). However, 
the bone diameter was not reduced, as often reported following retinoid excess (Hough 
et al. 1988; Johansson et al. 2002; Lind et al. 2006; Lind et al. 2011). In contrast, 
exposure of adult rats to TCDD in paper I caused reduced cross-sectional area, and 
also the perinatal exposure to TCDD in paper II and to Aroclor 1254 in paper IV 
resulted in smaller cross-sectional area, which is consistent with retinoid excess. These 
effects might be a result of increased periosteal resorption, but following perinatal 
exposure it may also reflect a decreased periosteal bone formation during development, 
leading to thinner bone.  
 
The increased mineral density of the trabecular bone, and the decreased cortical bone 
mineral density, that were associated with a higher serum retinol level following 
TCDD-exposure in paper III, are in line with findings showing compartment-specific 
impact of retinoids on bone. Retinoid excess has been suggested to cause increased 
periosteal bone resorption, but suppressed endosteal bone resorption (Kneissel et al. 
2005), as well as inhibition of cortical bone formation and increased endosteal 
mineralization (Lind et al. 2012). Because of the harder and stiffer bone matrix 
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following TCDD-exposure in paper III, which resembles characteristics of more 
mature bone, the TCDD-induced increase of trabecular bone might reflect impaired 
bone remodeling rather than increased endosteal mineralization. This is also in line 
with the decreased expression of differentiation marker genes in the osteoblastic cells 
following TCDD-exposure in vitro. 
 
The bone phenotype following TCDD-exposure did not fully reproduce the bone 
properties characteristic for retinoid excess, suggesting that other factors beyond the 
serum retinol levels are likely to be involved in mediating the observed bone effects. It 
might be that TCDD-induced alteration of retinoid metabolism and signaling within 
bone cells, as indicated by the altered expression of retinoid-related genes observed in 
osteoblastic cells in vitro, contribute to the effect pattern, although it is not clear if this 
is a relevant mechanism also in vivo. The increased expression of RALDH3 and 
decreased expression of CYP26a1 could indicate increased levels of retinoic acid in the 
cells. However, as exposure to TCDD also resulted in reduced expression of ALP and 
OCN, while OCN has been reported to be upregulated by retinoic acid (Oliva et al. 
1993; Thaweboon et al. 2005), the decreased expression of OCN in the present study 
might reflect suppression of retinoic acid-induced transcriptional activity (Weston et al. 
1995) or decreased retinoic acid-responsiveness (Rushing and Denison 2002) by 
TCDD, and the alterations in expression of retinoid-related genes being a compensatory 
mechanism.  
 
A number of studies have reported increased osteoblast differentiation and 
mineralization by retinoic acid in vitro (Malladi et al. 2006; Skillington et al. 2002; 
Song et al. 2005; Wan et al. 2007; Yamashita et al. 2005), but there are also studies 
reporting decreased mineralization (Cohen-Tanugi and Forest 1998; Iba et al. 2001; 
Nuka et al. 1997), as well as different effects depending on the stage of osteoblast 
differentiation (Nagasawa et al. 2005; Nakayama et al. 1990; Nuka et al. 1997). As 
retinoic acid is suggested to be involved in regulation of osteoblast and adipocyte 
differentiation from mesenchymal stem cells (Ding et al. 2001; Hisada et al. 2013; 
Skillington et al. 2002), it is possible that exposure to potent AhR-ligands, via 
alterations of the retinoid signaling system, may shift the fate of the mesenchymal stem 
cells and thereby impact osteogenesis. Further, elevated retinoic acid levels have been 
reported to promote osteoblast-to-osteocyte transitioning (Laue et al. 2011), and it 
could be speculated that altered retinoic acid signaling within osteoblastic cells result in 
an inappropriate osteocyte differentiation, which are expected to impact the bone 
properties. Furthermore, both stimulatory and inhibitory effects of retinoic acid on 
different phases of osteoclast differentiation and activity has been shown (Balkan et al. 
2011; Conaway et al. 2011; Hu et al. 2010; Kindmark et al. 1995; Saneshige et al. 
1995; Scheven and Hamilton 1990; Togari et al. 1991). Thus, also modulations of 
osteoclasts by retinoid signaling may be influencing the bone remodeling following 
dioxin exposure.  
 
In addition to AhR-ligands, other environmental chemicals, suspected to belong to the 
EDC-type of compounds, have the ability to both interact with the retinoid system and 
to affect bone. The brominated flame retardant hexabromocyclododecane (HBCD) 
decreased hepatic retinoid levels following perinatal exposure in rats, which also 
showed decreased trabecular bone mineral density, bone diameter and cortical 
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thickness (van der Ven et al. 2009). The organotin compound tributyltin (TBT), which 
is a ligand of the RXR (le Maire et al. 2009), has been shown to delay ossification of 
the skeleton in rat foetuses following prenatal exposure (Adeeko et al. 2003), and to 
affect osteoblast (Koskela et al. 2012) and osteoclast (Koskela et al. 2012; Yonezawa et 
al. 2007) differentiation in vitro. Effects on ostoclastogenesis were demonstrated to be 
inhibited by a RAR antagonist, suggesting involvement of a retinoid dependent 
pathway for the effects (Yonezawa et al. 2007). These findings, together with the 
observations in the present study, strengthen the relevance of the retinoid system as an 
important pathway in bone toxicity by EDCs.  
 
 
4.4 BENCHMARKDOSE MODELING OF BONE PARAMETERS  
In paper I, the BMD approach was applied for the bone parameters affected by TCDD 
in order to derive BMDs and to evaluate the usefulness of the approach for quantitative 
assessment of bone toxicity parameters. The BMDLs corresponding to an effect level 
of 5% were in general consistent with the corresponding NOAELs, while the 10% 
effect level resulted in BMDLs higher than the NOAEL values for most parameters. As 
bone has not traditionally been used as an endpoint in environmental toxicology 
studies, information about effect levels in relation to adversity of the outcome for the 
various parameters are scarce. The consistency of the BMDLs with the NOAELs in 
paper I suggests that the BMD approach is appropriate for evaluation of these 
parameters, and that the 5% effect level is relevant. However, although NOAEL values 
have been widely used in risk assessment, these values are rough measures of no-effect-
levels and highly dependent on the experimental dose levels. The fact that the NOAELs 
in this study were in the same range as the BMDLs at a 5% effect level, indicates that 
they did not represent no-effect-levels but rather correspond to an effect size of 5%.  
 
As an approach to evaluate the potency of Aroclor 1254 to induced bone effects in 
paper IV, for which only one dose level was available, the effect size resulting from 
the actual exposure was used as the CES for deriving BMDs for the same parameters 
affected by TCDD in a similarly designed study. The resulting ratio between the TCDD 
equivalents and the theoretical REP values, were consistent with the corresponding 
results from effects of Aroclor 1254 on osteoblasts in vitro in paper V, suggesting this 
approach to be appropriate. Further, in paper V, BMDs with a CES of 5% (BMD5) 
were calculated. For TCDD exposure, the BMD5 values were similar to the doses 
inducing significant effects as analyzed by ANOVA, while the BMD5 values for 
Aroclor 1254 were several potencies lower. The BMD5 reflects the point-of-departure 
of a dose-response curve, and due to the smaller effect size and less steep dose-
response curve for Aroclor 1254, the BMD5 method was in this case demonstrated to be 
more sensitive than ANOVA in identifying the dose-range where the effects start. This 
is supporting the use of BMD methodology to derive point-of-departure from dose-
response curves in bone toxicity studies for use in risk assessment. 
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5 CONCLUSIONS  
 
The quality and strength of bone tissue depends on both its structural and material 
properties. As any modification of these properties influences bone tissue quality, it is 
of value to examine the bone at various levels of its different compartments in order to 
provide insight into the consequences that exposure to various chemicals might have on 
bone. In this thesis, both geometrical, micro-structural, matrix material and macro-
mechanical parameters of the bone have been examined. In addition, cell studies and 
gene expression analyzes were performed in order to elucidate effects on the osteoblast 
differentiation process. 
From these studies it is clear that bone tissue is affected by exposure to potent AhR-
ligands such as dioxins, and that the AhR plays a crucial role for the manifestation of 
the effects. The presence or absence of a functional AhR also impacts the normal bone 
phenotype. Further, the outcome of the exposure is clearly influenced by the timing of 
exposure. Perinatal exposure to TCDD resulted in delayed matrix maturation, while 
exposure during adulthood caused a harder and stiffer bone matrix. The effect pattern 
and effect size was also observed to differ partly between the genders.  
On the cellular level, osteoblast differentiation was shown to be a target for TCDD-
exposure, which is consistent with the observed disturbances of bone mineralization 
following in vivo exposure. Further, exposure of osteoblastic cells to TCDD altered the 
expression of retinoid-related genes, which might reflect a contributing mode-of-action 
for the observed bone effect pattern. In addition, effects on bone properties following 
exposure to TCDD in vivo were associated with altered serum retinoid levels, which 
may influence the bone tissue modulations.   
Exposure to the PCB-mixture Aroclor 1254, which contains both dioxin-like and non-
dioxin-like congeners, caused a similar pattern of bone alterations as TCDD-exposure 
alone, both on bone properties in vivo and on osteoblastic cells in vitro, with the effects 
being mainly driven by the dioxin-like congeners in the mixture.  
Based on the observations in the experimental models in this study, the overall results 
show that environmental contaminants, to which humans are continuously exposed, 
have the ability to modulate the osteogenesis process, and suggest that the alterations of 
bone tissue are relevant endpoints in studies of effects of dioxin exposure. Taken 
together with data from studies showing bone effects by compounds with different 
modes-of-action, bone is likely to be useful as a model for studying health effects of 
chemicals also beyond dioxins.  
 
 
 
 
 
 
   29 
6 FUTURE PERSPECTIVES 
 
This thesis has characterized dioxin-induced bone tissue modulations. Further 
evaluation of bone toxicity profiles for certain types of mode-of-action is needed in 
order to establish bone alterations as reliable effect markers for various types of 
chemicals, and for development of test systems for chemicals with bone-toxic 
properties.  
As the exposure to environmental contaminants is always as combinations of multiple 
chemicals, whose interactions and impact on each other’s toxic effects are mostly 
unknown, disturbances of bone properties should be further evaluated following 
combined exposure. For example, interactions between organochlorines and other 
groups of compounds, such as perfluorinated compounds, as well as metals, are of high 
relevance for the current exposure situation.  
In order to clarify the impact of an altered retinoid signaling for dioxin-induced bone 
modulations, the expression of retinoid-related genes in bone following dioxin 
exposure should also be examined in vivo. In addition, interactions of the AhR- and 
retinoid systems with other signaling pathways should be taken into account. 
The contribution of a disturbed osteoclastogenesis for the observed effects, and possible 
effects on the coupling between osteoblast and osteoclast activities, would be of interest 
to explore. 
Based on the inter-relationship between cells of mesenchymal linages, future studies 
should address the possibility that disturbances of the relation between osteogenesis, 
adipogenesis and chondrogenesis, are involved in the observed bone effects by 
environmental chemicals. Also possible effects on osteocyte differentiation should be 
addressed. Further, increasing evidence links exposure to environmental chemicals to 
epigenetic alterations, and as epigenetic regulation are shown to contribute to linage-
specific differentiation of mesenchymal stem cells, it would be of interest to investigate 
whether epigenetic modifications of genes regulating osteogenesis could be an 
underlying mechanism for the affected bone tissue properties.   
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